1. Home
  2. CTKB vs PHH Comparison

CTKB vs PHH Comparison

Compare CTKB & PHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • PHH
  • Stock Information
  • Founded
  • CTKB 1990
  • PHH 2016
  • Country
  • CTKB United States
  • PHH China
  • Employees
  • CTKB N/A
  • PHH N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PHH Package Goods/Cosmetics
  • Sector
  • CTKB Health Care
  • PHH Consumer Discretionary
  • Exchange
  • CTKB Nasdaq
  • PHH Nasdaq
  • Market Cap
  • CTKB 450.9M
  • PHH 363.4M
  • IPO Year
  • CTKB 2021
  • PHH 2024
  • Fundamental
  • Price
  • CTKB $3.61
  • PHH $39.80
  • Analyst Decision
  • CTKB Hold
  • PHH
  • Analyst Count
  • CTKB 4
  • PHH 0
  • Target Price
  • CTKB $6.00
  • PHH N/A
  • AVG Volume (30 Days)
  • CTKB 1.6M
  • PHH 684.2K
  • Earning Date
  • CTKB 08-05-2025
  • PHH 01-01-0001
  • Dividend Yield
  • CTKB N/A
  • PHH N/A
  • EPS Growth
  • CTKB N/A
  • PHH N/A
  • EPS
  • CTKB N/A
  • PHH 0.02
  • Revenue
  • CTKB $197,050,000.00
  • PHH $2,381,851.00
  • Revenue This Year
  • CTKB $0.91
  • PHH N/A
  • Revenue Next Year
  • CTKB $7.75
  • PHH N/A
  • P/E Ratio
  • CTKB N/A
  • PHH $2,094.25
  • Revenue Growth
  • CTKB N/A
  • PHH N/A
  • 52 Week Low
  • CTKB $2.37
  • PHH $3.70
  • 52 Week High
  • CTKB $7.63
  • PHH $39.91
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 60.87
  • PHH N/A
  • Support Level
  • CTKB $3.38
  • PHH N/A
  • Resistance Level
  • CTKB $3.65
  • PHH N/A
  • Average True Range (ATR)
  • CTKB 0.21
  • PHH 0.00
  • MACD
  • CTKB 0.04
  • PHH 0.00
  • Stochastic Oscillator
  • CTKB 91.61
  • PHH 0.00

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About PHH Park Ha Biological Technology Co. Ltd. Ordinary Shares

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.

Share on Social Networks: